or Try an Advanced Search...

    Two River Stocks List

    Symbol Grade Name % Change
    LQDA D Liquidia Technologies, Inc. -3.09
    CAPR D Capricor Therapeutics, Inc. 4.56
    RFL F Rafael Holdings, Inc. 0.00
    GMDA F Gamida Cell Ltd. 0.00
    ENZ F Enzo Biochem, Inc. -2.75
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research
    Related Stock Lists: Life Sciences Biotechnology Cancer Biopharmaceutical Cardiovascular Disease Acid Antibodies Autoimmune Disease Biochemistry Biology Bupivacaine Cancer Cell Clinical Research Clinical Trial Cyclacel Diabetes Diagnostic And Research Products Drug Development Dyes Endocrine Disorders

    Related ETFs - A few ETFs which own one or more of the above listed Two River stocks.

    Symbol Grade Name Weight
    PTH D Invesco DWA Healthcare Momentum ETF 1.85
    BBC D Virtus LifeSci Biotech Clinical Trials ETF 1.52
    XPH D SPDR S&P Pharmaceuticals ETF 1.17
    PILL F Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF 0.89
    SBIO D ALPS Medical Breakthroughs ETF 0.69
    View all Two River ETFs...
    Compare ETFs
    Compare BBC to XPH Compare PTH to XPH Compare XPH to PILL

        Two River Stocks Recent News

        Date Stock Title
        Apr 24 CAPR Here's Why We're Not Too Worried About Capricor Therapeutics' (NASDAQ:CAPR) Cash Burn Situation
        Apr 24 CAPR Capricor Therapeutics Announces Positive Type-B Meeting with FDA for CAP-1002 Program for Duchenne Muscular Dystrophy
        Apr 24 LQDA When Will Liquidia Corporation (NASDAQ:LQDA) Become Profitable?
        Related Industries: Biotechnology Diagnostics & Research
        Related Stock Lists: Life Sciences Biotechnology Cancer Biopharmaceutical Cardiovascular Disease Acid Antibodies Autoimmune Disease Biochemistry Biology Bupivacaine Cancer Cell Clinical Research Clinical Trial Cyclacel Diabetes Diagnostic And Research Products Drug Development Dyes Endocrine Disorders
        Two River

        Two River Group Holdings is a New York-based venture capital firm and merchant bank focused on the life science sector. It specializes in investments in life science, biotechnology, and in firms focused on developing preventative and therapeutic technologies for a broad spectrum of disease areas including oncology, cardiovascular disease, neurological disorders, and companion animal health care.Two River was founded in September 2004 by partners Joshua Kazam, Peter Kash, David Tanen and Benjamin Bernstein. Dr. Arie Belldegrun joined the firm in 2008 as Chairman and Partner.The firm has offices in New York City and Los Angeles.

        More about Two River
        Browse All Tags